ReviewCritical care (London, England)2026
Revised french military transfusion doctrine for large-scale combat operations: a consensus framework.
Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLarge-scale combat operations (LSCO) pose unique logistical and clinical challenges to haemorrhagic casualty management. The existing French military transfusion doctrine, originally designed for low-intensity conflicts (LIC), does not meet the demands of LSCO. This work aimed to develop a revised, consensus-based transfusion doctrine integrating operational, medical, and safety requirements for LSCO environments.
methodsAt the request of the Central Directorate of the Military Health Service, a Delphi-based consensus process was conducted between November 2024 and April 2025. Eight senior military physicians—anaesthesiologist-intensivists, emergency and operational clinicians, and medical biologists with over five years of specialty experience—reviewed eleven thematic domains identified for revision. Drafts, developed from doctrinal texts, operational feedback, and international literature (including systematic reviews), were iteratively refined through three Delphi cycles until full consensus (100%) was reached. This consensus reflects expert doctrinal guidance for LSCO operational preparedness under limited/heterogeneous evidence rather than proof of clinical efficacy. The resulting doctrine was compared with the previous LIC framework and international LSCO transfusion strategies.
resultsThe new doctrine establishes a scalable, safety-focused system integrating forward whole-blood resuscitation, enhanced logistical autonomy, and reinforced haemovigilance. Cold-stored whole blood will be prioritised as the primary resuscitation product for Roles 1 and 2, while Role 3 will employ component therapy. A new dedicated operational medical unit will oversee in-theatre collection, testing, and distribution. Forward transfusion by trained nurses using universal blood products under predefined criteria will be authorised, with strict traceability and targeted training ensuring transfusion safety in LSCO.
conclusionsThis consensus defines the modern French transfusion doctrine for LSCO, combining operational flexibility with rigorous safety oversight and alignment with international standards.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.